Elura is a drug owned by ELANCO US INC. It is protected by 2 US drug patents filed from 2034 to 2036. All patents are active. Details of Elura’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US9499543 | 28 May, 2034 | Active |
Exclusivity Information
Elura holds 1 exclusivity out of which 1 has expired. Details of Elura's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Oct 16, 2023 |
About Elura
Elura is a drug
owned by ELANCO US INC.
Elura uses
Capromorelin as the active
ingredient.
Active Ingredient:
Elura uses
Capromorelin as the active ingredient.
Check out other Drugs and Companies using
Capromorelin ingredient.